{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:09:31Z","timestamp":1778706571081,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Iceland research fund"},{"DOI":"10.13039\/501100001840","name":"Icelandic Center for Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Icelandic Center for Research (RANN&amp;#x00CD;S) University of Iceland research fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aroylated phenylenediamines (APDs) are novel inducers of innate immunity enhancing cathelicidin gene expression in human bronchial epithelial cell lines. Here we present two newly developed APDs and aimed at defining the response and signaling pathways for these compounds with reference to innate immunity and antimicrobial peptide (AMP) expression. Induction was initially defined with respect to dose and time and compared with the APD Entinostat (MS-275). The induction applies to several innate immunity effectors, indicating that APDs trigger a broad spectrum of antimicrobial responses. The bactericidal effect was shown in an infection model against <jats:italic>Pseudomonas aeruginosa<\/jats:italic> by estimating bacteria entering cells. Treatment with a selected APD counteracted <jats:italic>Pseudomonas<\/jats:italic> mediated disruption of epithelial integrity. This double action by inducing AMPs and enhancing epithelial integrity for one APD compound is unique and taken as a positive indication for host directed therapy (HDT). The APD effects are mediated through Signal transducer and activator of transcription 3 (STAT3) activation. Utilization of induced innate immunity to fight infections can reduce antibiotic usage, might be effective against multidrug resistant bacteria and is in line with improved stewardship in healthcare.<\/jats:p>","DOI":"10.1038\/s41598-019-43350-z","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:35:48Z","timestamp":1557416148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel aroylated phenylenediamine compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity"],"prefix":"10.1038","volume":"9","author":[{"given":"Iwona T.","family":"Myszor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahida","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Ottosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Agerberth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur H.","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"43350_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/mi.2017.71","volume":"11","author":"MM Leiva-Ju\u00e1rez","year":"2018","unstructured":"Leiva-Ju\u00e1rez, M. M., Kolls, J. K. & Evans, S. E. Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol. 11, 21\u201334 (2018).","journal-title":"Mucosal Immunol."},{"key":"43350_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14582","author":"S Hasan","year":"2018","unstructured":"Hasan, S., Sebo, P. & Osicka, R. A guide to polarized airway epithelial models for studies of host-pathogen interactions. FEBS J. https:\/\/doi.org\/10.1111\/febs.14582 (2018).","journal-title":"FEBS J."},{"key":"43350_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI0215217","volume":"109","author":"MR Knowles","year":"2002","unstructured":"Knowles, M. R. & Boucher, R. C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571\u20137 (2002).","journal-title":"J. Clin. Invest."},{"key":"43350_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy, J. V. & Dickey, B. F. Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233\u201347 (2010).","journal-title":"N. Engl. J. Med."},{"key":"43350_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","volume":"124","author":"R Bansil","year":"2018","unstructured":"Bansil, R. & Turner, B. S. The biology of mucus: Composition, synthesis and organization. Adv. Drug Deliv. Rev. 124, 3\u201315 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"43350_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.it.2014.07.004","volume":"35","author":"SC Mansour","year":"2014","unstructured":"Mansour, S. C., Pena, O. M. & Hancock, R. E. W. Host defense peptides: front-line immunomodulators. Trends Immunol. 35, 443\u2013450 (2014).","journal-title":"Trends Immunol."},{"key":"43350_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1073\/pnas.92.1.195","volume":"92","author":"B Agerberth","year":"1995","unstructured":"Agerberth, B. et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92, 195\u20139 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43350_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","volume":"238","author":"GH Gudmundsson","year":"1996","unstructured":"Gudmundsson, G. H. et al. The Human Gene FALL39 and Processing of the Cathelin Precursor to the Antibacterial Peptide LL-37 in Granulocytes. Eur. J. Biochem. 238, 325\u2013332 (1996).","journal-title":"Eur. J. Biochem."},{"key":"43350_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nri2433","volume":"8","author":"JK Kolls","year":"2008","unstructured":"Kolls, J. K., McCray, P. B., Chan, Y. R. & Chan, Y. R. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8, 829\u201335 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"43350_CR10","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1128\/IAI.70.6.3068-3072.2002","volume":"70","author":"C Moser","year":"2002","unstructured":"Moser, C. et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068\u201372 (2002).","journal-title":"Infect. Immun."},{"key":"43350_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4049\/jimmunol.1103196","volume":"189","author":"MA Kovach","year":"2012","unstructured":"Kovach, M. A. et al. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J. Immunol. 189, 304\u201311 (2012).","journal-title":"J. Immunol."},{"key":"43350_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","volume":"30","author":"Y Lai","year":"2009","unstructured":"Lai, Y. & Gallo, R. L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30, 131\u2013141 (2009).","journal-title":"Trends Immunol."},{"key":"43350_CR13","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/IAI.00936-15","volume":"83","author":"F Torres-Juarez","year":"2015","unstructured":"Torres-Juarez, F. et al. LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages. Infect. Immun. 83, 4495\u2013503 (2015).","journal-title":"Infect. Immun."},{"key":"43350_CR14","doi-asserted-by":"publisher","first-page":"L842","DOI":"10.1152\/ajplung.00286.2004","volume":"289","author":"R Shaykhiev","year":"2005","unstructured":"Shaykhiev, R. et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Cell. Mol. Physiol. 289, L842\u2013L848 (2005).","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"43350_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","volume":"6","author":"J-M Yuk","year":"2009","unstructured":"Yuk, J.-M. et al. Vitamin D3 Induces Autophagy in Human Monocytes\/Macrophages via Cathelicidin. Cell Host Microbe 6, 231\u2013243 (2009).","journal-title":"Cell Host Microbe"},{"key":"43350_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1080\/15548627.2015.1075110","volume":"11","author":"RS Rekha","year":"2015","unstructured":"Rekha, R. S. et al. Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages. Autophagy 11, 1688\u201399 (2015).","journal-title":"Autophagy"},{"key":"43350_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389\u2013395 (2002).","journal-title":"Nature"},{"key":"43350_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L. B. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE. J. Infect. Dis. 197, 1079\u20131081 (2008).","journal-title":"J. Infect. Dis."},{"key":"43350_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmi.2014.12.025","volume":"21","author":"JM Pogue","year":"2015","unstructured":"Pogue, J. M., Kaye, K. S., Cohen, D. A. & Marchaim, D. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin. Microbiol. Infect. 21, 302\u2013312 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"43350_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm.2715","volume":"18","author":"TS Cohen","year":"2012","unstructured":"Cohen, T. S. & Prince, A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18, 509\u2013519 (2012).","journal-title":"Nat. Med."},{"key":"43350_CR21","doi-asserted-by":"publisher","first-page":"e0138340","DOI":"10.1371\/journal.pone.0138340","volume":"10","author":"A Mily","year":"2015","unstructured":"Mily, A. et al. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial. PLoS One 10, e0138340 (2015).","journal-title":"PLoS One"},{"key":"43350_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12767","author":"A Bekele","year":"2018","unstructured":"Bekele, A. et al. Daily adjunctive therapy with vitamin D 3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia. J. Intern. Med. https:\/\/doi.org\/10.1111\/joim.12767 (2018).","journal-title":"J. Intern. Med."},{"key":"43350_CR23","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"T-T Wang","year":"2004","unstructured":"Wang, T.-T. et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173, 2909\u201312 (2004).","journal-title":"J. Immunol."},{"key":"43350_CR24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.0022-202X.2005.23687.x","volume":"124","author":"G Weber","year":"2005","unstructured":"Weber, G. et al. Vitamin D Induces the Antimicrobial Protein hCAP18 in Human Skin. J. Invest. Dermatol. 124, 1080\u20131082 (2005).","journal-title":"J. Invest. Dermatol."},{"key":"43350_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart, A. F., Borregaard, N. & Koeffler, H. P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D 3. FASEB J. 19, 1067\u20131077 (2005).","journal-title":"FASEB J."},{"key":"43350_CR26","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1128\/AAC.00818-09","volume":"53","author":"J Steinmann","year":"2009","unstructured":"Steinmann, J., Halld\u00f3rsson, S., Agerberth, B. & Gudmundsson, G. H. Phenylbutyrate induces antimicrobial peptide expression. Antimicrob. Agents Chemother. 53, 5127\u201333 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"43350_CR27","doi-asserted-by":"publisher","first-page":"e20637","DOI":"10.1371\/journal.pone.0020637","volume":"6","author":"P Sarker","year":"2011","unstructured":"Sarker, P. et al. Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy. PLoS One 6, e20637 (2011).","journal-title":"PLoS One"},{"key":"43350_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","volume":"11","author":"T Iannitti","year":"2011","unstructured":"Iannitti, T. & Palmieri, B. Clinical and experimental applications of sodium phenylbutyrate. Drugs R. D. 11, 227\u201349 (2011).","journal-title":"Drugs R. D."},{"key":"43350_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep33274","volume":"6","author":"E Miraglia","year":"2016","unstructured":"Miraglia, E. et al. Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1\u03b1 transcription factors. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"43350_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep36692","volume":"6","author":"H Ottosson","year":"2016","unstructured":"Ottosson, H. et al. Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"43350_CR31","doi-asserted-by":"publisher","first-page":"e02570","DOI":"10.1128\/AAC.02570-16","volume":"61","author":"P Sarker","year":"2017","unstructured":"Sarker, P. et al. Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia. Antimicrob. Agents Chemother. 61, e02570\u201316 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"43350_CR32","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1517\/13543784.2011.613822","volume":"20","author":"J Knipstein","year":"2011","unstructured":"Knipstein, J. & Gore, L. Entinostat for treatment of solid tumors and hematologic malignancies. Expert Opin. Investig. Drugs 20, 1455\u20131467 (2011).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"43350_CR33","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1200\/JCO.2005.02.188","volume":"23","author":"QC Ryan","year":"2005","unstructured":"Ryan, Q. C. et al. Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J. Clin. Oncol. 23, 3912\u201322 (2005).","journal-title":"J. Clin. Oncol."},{"key":"43350_CR34","doi-asserted-by":"publisher","first-page":"e92919","DOI":"10.1371\/journal.pone.0092919","volume":"9","author":"JJ Cody","year":"2014","unstructured":"Cody, J. J., Markert, J. M. & Hurst, D. R. Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells. PLoS One 9, e92919 (2014).","journal-title":"PLoS One"},{"key":"43350_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1753425913493338","volume":"20","author":"F Nyl\u00e9n","year":"2014","unstructured":"Nyl\u00e9n, F. et al. Boosting innate immunity: Development and validation of a cell-based screening assay to identify LL-37 inducers. Innate Immun. 20, 364\u2013376 (2014).","journal-title":"Innate Immun."},{"key":"43350_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1465-9921-11-96","volume":"11","author":"H Wu","year":"2010","unstructured":"Wu, H. et al. Lipocalin 2 is protective against E. coli pneumonia. Respir. Res. 11, 96 (2010).","journal-title":"Respir. Res."},{"key":"43350_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.physiol.64.081501.134340","volume":"64","author":"BC Schutte","year":"2002","unstructured":"Schutte, B. C. & McCray, P. B. \u03b2-Defensins in Lung Host Defense. Annu. Rev. Physiol. 64, 709\u2013748 (2002).","journal-title":"Annu. Rev. Physiol."},{"key":"43350_CR38","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1128\/IAI.69.6.3692-3696.2001","volume":"69","author":"K Nisapakultorn","year":"2001","unstructured":"Nisapakultorn, K., Ross, K. F. & Herzberg, M. C. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect. Immun. 69, 3692\u20136 (2001).","journal-title":"Infect. Immun."},{"key":"43350_CR39","doi-asserted-by":"publisher","first-page":"e24997","DOI":"10.4161\/tisb.24997","volume":"1","author":"S Ganesan","year":"2013","unstructured":"Ganesan, S., Comstock, A. T. & Sajjan, U. S. Barrier function of airway tract epithelium. Tissue barriers 1, e24997 (2013).","journal-title":"Tissue barriers"},{"key":"43350_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","volume":"36","author":"C Bogdan","year":"2015","unstructured":"Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36, 161\u2013178 (2015).","journal-title":"Trends Immunol."},{"key":"43350_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-14-135","volume":"14","author":"MS Walters","year":"2013","unstructured":"Walters, M. S. et al. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity. Respir. Res. 14, 135 (2013).","journal-title":"Respir. Res."},{"key":"43350_CR42","doi-asserted-by":"publisher","first-page":"e1005377","DOI":"10.1371\/journal.ppat.1005377","volume":"12","author":"G Golovkine","year":"2016","unstructured":"Golovkine, G. et al. Pseudomonas aeruginosa Transmigrates at Epithelial Cell-Cell Junctions, Exploiting Sites of Cell Division and Senescent Cell Extrusion. PLoS Pathog. 12, e1005377 (2016).","journal-title":"PLoS Pathog."},{"key":"43350_CR43","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/IAI.01772-05","volume":"74","author":"L Zulianello","year":"2006","unstructured":"Zulianello, L. et al. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect. Immun. 74, 3134\u201347 (2006).","journal-title":"Infect. Immun."},{"key":"43350_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1165\/rcmb.2008-0357OC","volume":"42","author":"S Halldorsson","year":"2010","unstructured":"Halldorsson, S. et al. Azithromycin Maintains Airway Epithelial Integrity during Pseudomonas aeruginosa Infection. Am. J. Respir. Cell Mol. Biol. 42, 62\u201368 (2010).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"43350_CR45","unstructured":"CDC. Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (2013)."},{"key":"43350_CR46","doi-asserted-by":"publisher","first-page":"E2993","DOI":"10.1073\/pnas.1605997113","volume":"113","author":"N Fischer","year":"2016","unstructured":"Fischer, N. et al. Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge. Proc. Natl. Acad. Sci. USA 113, E2993\u20133001 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43350_CR47","doi-asserted-by":"publisher","first-page":"E9869","DOI":"10.1073\/pnas.1805298115","volume":"115","author":"E Sechet","year":"2018","unstructured":"Sechet, E., Telford, E., Bonamy, C., Sansonetti, P. J. & Sperandio, B. Natural molecules induce and synergize to boost expression of the human antimicrobial peptide \u03b2-defensin-3. Proc. Natl. Acad. Sci. USA 115, E9869\u2013E9878 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43350_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27012-0","volume":"8","author":"S Jatana","year":"2018","unstructured":"Jatana, S. et al. Pyrimidine synthesis inhibition enhances cutaneous defenses against antibiotic resistant bacteria through activation of NOD2 signaling. Sci. Rep. 8, 8708 (2018).","journal-title":"Sci. Rep."},{"key":"43350_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11626-007-9050-4","volume":"43","author":"S Halldorsson","year":"2007","unstructured":"Halldorsson, S. et al. Differentiation potential of a basal epithelial cell line established from human bronchial explant. Vitr. Cell. Dev. Biol. - Anim. 43, 283\u2013289 (2007).","journal-title":"Vitr. Cell. Dev. Biol. - Anim."},{"key":"43350_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2015.181","volume":"12","author":"KJ Menzies","year":"2016","unstructured":"Menzies, K. J., Zhang, H., Katsyuba, E. & Auwerx, J. Protein acetylation in metabolism \u2014 metabolites and cofactors. Nat. Rev. Endocrinol. 12, 43\u201360 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"43350_CR51","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon, A., Goldrath, A. W., Nizet, V. & Johnson, R. S. HIF transcription factors, inflammation, and immunity. Immunity 41, 518\u201328 (2014).","journal-title":"Immunity"},{"key":"43350_CR52","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1097\/MIB.0000000000000421","volume":"21","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation. Inflamm. Bowel Dis. 21, 1894\u20131907 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"43350_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00441-010-1044-y","volume":"343","author":"LJ Quinton","year":"2011","unstructured":"Quinton, L. J. & Mizgerd, J. P. NF-\u03baB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res. 343, 153\u2013165 (2011).","journal-title":"Cell Tissue Res."},{"key":"43350_CR54","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.kint.2017.12.006","volume":"93","author":"CB Ching","year":"2018","unstructured":"Ching, C. B. et al. Interleukin-6\/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection. Kidney Int. 93, 1320\u20131329 (2018).","journal-title":"Kidney Int."},{"key":"43350_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1203\/00006450-200302000-00003","volume":"53","author":"H Yoshio","year":"2003","unstructured":"Yoshio, H. et al. Antimicrobial Polypeptides of Human Vernix Caseosa and Amniotic Fluid: Implications for Newborn Innate Defense. Pediatr. Res. 53, 211\u2013216 (2003).","journal-title":"Pediatr. Res."},{"key":"43350_CR56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1021\/jo00242a022","volume":"53","author":"RH Smith","year":"1988","unstructured":"Smith, R. H., Mehl, A. F., Shantz, D. L., Chmurny, G. N. & Michejda, C. J. Novel cross-linking alkylating agents, 1-(2-chloroethyl)-3-methyl-3-acyltriazenes. J. Org. Chem. 53, 1467\u20131471 (1988).","journal-title":"J. Org. Chem."},{"key":"43350_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"43350_CR58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.molimm.2014.10.007","volume":"63","author":"NN Kulkarni","year":"2015","unstructured":"Kulkarni, N. N., Yi, Z., Huehnken, C., Agerberth, B. & Gudmundsson, G. H. Phenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways. Mol. Immunol. 63, 530\u2013539 (2015).","journal-title":"Mol. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43350-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43350-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:22:55Z","timestamp":1671268975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43350-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43350-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"31 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.T.M., Z.P. and H.O. declare no competing interests. G.H.G., B.A. and R.S. are founders and stockholders in Akthelia Pharmaceuticals that hold a patent on APD compounds, Patent No. US 9,957,226 B2. P.B. is a stockholder in Akthelia Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7114"}}